sanofi pasteur — The vaccines business of sanofi-aventis Group
Protect
VaccinePlace.com -- Search.  Know more.
Explore Protect Learn
Call to Arms For Pertussis Logo
Image of Adolescents and Adults after Pertussis Vaccine Injection

ADACEL VACCINE PATIENT INFORMATION

 

View text document of the ADACEL vaccine Patient Information

Image Link for Adacel Patient Information

Download PDF document of the ADACEL vaccine Patient Information

 

 

 

SAFETY INFORMATION

Indication
Adacel vaccine is given as a single dose to people 11 through 64 years of age for active booster immunization for the prevention of tetanus (lockjaw), diphtheria, and pertussis (whooping cough).

Safety Information
Side effects to Adacel vaccine include injection site pain, redness, and swelling; headache, body ache, tiredness, and fever. Tell your doctor if you have ever experienced a severe brain disorder, such as encephalopathy (altered consciousness) or Guillain-Barré syndrome (severe muscle weakness), after a previous dose of a tetanus toxoid- or pertussis-containing vaccine. Other side effects may occur. Vaccination with Adacel vaccine may not protect all people receiving the vaccine.

For more information about Adacel vaccine, talk to your health-care professional.

Last modified: 2/20/09

 
Provided as a service by Sanofi Pasteur Inc.
Copyright © 2010 Sanofi Pasteur Inc.
This page last updated: 11-Aug-2010